Мақола

PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER

H. V. NurmatovAndijan Institute of Mechanical EngineeringN.L. TojiboevaAndijan Institute of Mechanical EngineeringS.O. UsmonovaAndijan Institute of Mechanical EngineeringF.L. SaidjonovaAndijan Institute of Mechanical EngineeringG.L. BabaevaAndijan Institute of Mechanical Engineering

Экономика и социумjournal2020ru

ABI

Аннотация

"Prevention of venous thromboembolism in patients with cancer Risk of venous thromboembolism (vte) is elevated in cancer and leads to high mor¬bidity and mortality in this population. Drug prophylaxis is questionable, due hemor¬rhagic risk in these patients, and explains the importance of selecting high risk popu¬lation, depending on the type of cancer and on individual risk factors for thrombosis. While the indications for prevention are well established during hospitalization for an acute condition and during cancer surgery, mostly with low molecular weight heparin, questions persist as to the indication of prophylaxis for outpatients receiving chemo¬therapy, and to the place of direct oral anticoagulant in this indication."

Мавзулар

Venous Thromboembolism Diagnosis and Management Central Venous Catheters and Hemodialysis Cardiac tumors and thrombi

Идентификаторлар

DOI: 10.46566/2225-1545_2020_77_632

Иқтибослар ва манбалар

0 та иқтибос52 та фойдаланилган манба

Кўрсаткичлар — AkademScholar · Тез орада